SATO VICKI L — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

SATO VICKI L has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.79M.

Profile

Vicki L. Sato is a physician-scientist and biotechnology executive who serves as a director of Vir Biotechnology, Inc. She has a long-standing track record in the life sciences industry, with experience in biotech company leadership and governance. As of the most recent SEC filing on May 4, 2026, she held the role of Director at Vir Biotechnology.

Board memberships

• Vir Biotechnology, Inc.

Awards & honors

• Director, Vir Biotechnology, Inc. (as of 2026-05-04)
• Recognized biotechnology industry professional with governance experience

Recent Transactions

Companies — Last 90 Days

• Allogene Therapeutics, Inc. (ALLO) — 1 filings, last 2026-06-23
• Vir Biotechnology, Inc. (VIR) — 1 filings, last 2026-05-04

Frequently Asked Questions

Who is SATO VICKI L?

Vicki L. Sato is a physician-scientist and biotechnology executive who serves as a director of Vir Biotechnology, Inc. She has a long-standing track record in the life sciences industry, with experience in biotech company leadership and governance. As of the most recent SEC filing on May 4, 2026, she held the role of Director at Vir Biotechnology.…

How many SEC Form 4 filings has SATO VICKI L submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has SATO VICKI L been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 13 open-market sales ($1.79M) across all tracked filings.

Where can I see all of SATO VICKI L's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week